StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Sunday. The firm issued a hold rating on the stock.
China Pharma Price Performance
CPHI opened at $0.31 on Friday. China Pharma has a one year low of $0.27 and a one year high of $2.70. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.88 and a quick ratio of 0.33. The company’s 50 day simple moving average is $0.36 and its 200-day simple moving average is $0.46.
China Pharma Company Profile
Further Reading
- Five stocks we like better than China Pharma
- What is a Low P/E Ratio and What Does it Tell Investors?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the Shanghai Stock Exchange Composite Index?
- Hilton Demonstrates Asset Light is Right for Investors
- Canadian Penny Stocks: Can They Make You Rich?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
